Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA386740
Max Phase: Preclinical
Molecular Formula: C28H29N7O
Molecular Weight: 479.59
Molecule Type: Small molecule
Associated Items:
ID: ALA386740
Max Phase: Preclinical
Molecular Formula: C28H29N7O
Molecular Weight: 479.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1nc2c(=O)n(Cc3ccccc3)nc(CN3CCN(C)CC3)c2c2cc(-c3ccccc3)nn12
Standard InChI: InChI=1S/C28H29N7O/c1-20-29-27-26(25-17-23(31-35(20)25)22-11-7-4-8-12-22)24(19-33-15-13-32(2)14-16-33)30-34(28(27)36)18-21-9-5-3-6-10-21/h3-12,17H,13-16,18-19H2,1-2H3
Standard InChI Key: DMGXATVYJKAVLP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 479.59 | Molecular Weight (Monoisotopic): 479.2434 | AlogP: 3.21 | #Rotatable Bonds: 5 |
Polar Surface Area: 71.56 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.53 | CX LogP: 3.40 | CX LogD: 3.03 |
Aromatic Rings: 5 | Heavy Atoms: 36 | QED Weighted: 0.39 | Np Likeness Score: -1.45 |
1. Giovannoni MP, Vergelli C, Biancalani C, Cesari N, Graziano A, Biagini P, Gracia J, Gavaldà A, Dal Piaz V.. (2006) Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction., 49 (17): [PMID:16913726] [10.1021/jm060265+] |
Source(1):